ResearcherUCLouvainNo recent work listed

Françoise Derouane

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0199-1366; OpenAlex author ID A5015949584. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper

Papers 2

Inhibition of Mitochondrial Redox Signaling with MitoQ Prevents Metastasis of Human Pancreatic Cancer in Mice. Co-author DOI 10.3390/cancers14194918 ↗
When a metastatic breast cancer is mimicking a pancreatic cancer: case report and review of the literature. Co-author DOI 10.1080/17843286.2019.1607990 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Pierre Sonveaux · 1 shared paper, 2022 · strength 0.14
- Paper Inhibition of Mitochondrial Redox Signaling with MitoQ Prevents Metastasis of Human Pancreatic Cancer in Mice. DOI 10.3390/cancers14194918 ↗
Tânia Capelôa · 1 shared paper, 2022 · strength 0.14
- Paper Inhibition of Mitochondrial Redox Signaling with MitoQ Prevents Metastasis of Human Pancreatic Cancer in Mice. DOI 10.3390/cancers14194918 ↗
Paolo Ettore Porporato · 1 shared paper, 2022 · strength 0.14
- Paper Inhibition of Mitochondrial Redox Signaling with MitoQ Prevents Metastasis of Human Pancreatic Cancer in Mice. DOI 10.3390/cancers14194918 ↗
Halil Yıldız · 1 shared paper, 2020 · strength 0.13
- Paper When a metastatic breast cancer is mimicking a pancreatic cancer: case report and review of the literature. DOI 10.1080/17843286.2019.1607990 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.